Ascendis Pharma A (ASND) Short-term Investments (2020 - 2025)

Ascendis Pharma A (ASND) has 5 years of Short-term Investments data on file, last reported at $298.3 million in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments rose 85.25% year-over-year to $298.3 million; the trailing twelve-month figure through Dec 2025 stood at $298.3 million (up 85.25% YoY), and the FY2025 full-year result was $298.3 million, up 82.9% from the prior year.
• Short-term Investments climbed to $298.3 million in Q4 2025, from $161.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $298.3 million in Q4 2025 to a low of $1.3 million in Q1 2022.
• A 4-year average of $61.4 million and a median of $4.8 million in 2022 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments slumped 97.21% in 2021 and jumped 233.77% in 2022, its largest moves.
• Tracing ASND's Short-term Investments over 4 years: stood at $5.2 million in 2021, then jumped by 233.77% to $17.3 million in 2022, then soared by 830.65% to $161.0 million in 2024, then soared by 85.25% to $298.3 million in 2025.
• Business Quant data shows ASND's Short-term Investments at $298.3 million in Q4 2025, $161.0 million in Q4 2024, and $17.3 million in Q4 2022.